Dynamic scientist with unique expertise and knowledge of current research and industry trends, passionate about driving progress within the field of gene therapy and advancing products from preclinical development and into the clinic and beyond. ● Biomedical research scientist with over 15 years of experience in Adeno-associated Virus (AAV) biology and its applications in gene therapy ● Strong background in AAV-focused analytics, with experience in analytical development, project management, and CMC development ● Proficiency in managing collaborations with both internal and external research groups (including CDMOs and CROs) ● Proven ability to communicate complex topics to a wide variety of audiences, with expertise in scientific writing and speaking ● Patient-focused, curious and highly motivated, with great attention to detail, and the capacity to thrive in a fast-paced work environment Specialties: AAV biology, analytical development, novel capsid characterization, potency assays, gene therapy
Director | Analytical Development, Genomic Medicine at Alexion Pharmaceuticals, Inc.
Ph.D., Biochemistry and Molcular Biology, Structural Virology, Gene Therapy